FDA approves diagnostic device using flow and imaging cytometry

FDA approves diagnostic device using flow and imaging cytometry

PixCell Medical has developed an FDA-cleared platform intended for use at the Point-Of-Care (POC) that can deliver lab-quality full five-part differential Complete Blood Count (CBC) results and comprehensive abnormal cell flagging. PixCell’s HemoScreen diagnostic platform shortens diagnostic results delivery from days to minutes. 

Sourced through Scoop.it from: www.medicalplasticsnews.com

Who We Are

Omnica Corporation is a privately-held design, engineering, and medical product development firm located in Irvine, California. The 28-person company is staffed with full-time employees and has been in operation since 1984. Our speciality is custom product development for the medical industry and industrial fields.

Our expertise is developing complex medical devices.Technical personnel at Omnica includes designers, mechanical engineers, electronic and software engineers, advanced R&D specialists, regulatory staff (for FDA documentation), machinists and model makers.

Learn MoreOmnica Corporation

Leave a Reply

Your email address will not be published. Required fields are marked *